Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” Marketing of Wegovy(R) Triggers Securities Class Actions – HIMS Investors with Losses Encouraged to Contact Hagens Berman

Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” Marketing of Wegovy(R) Triggers Securities Class Actions – HIMS Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire July 17, 2025 SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) — On June 25, 2025, securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) […]

OGN Deadline: OGN Investors with Losses in Excess of $100K Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline. So what:If you purchased Organon securities during the Class Period you may

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action- Hagens Berman

(NasdaqGM:RCKT), SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) — When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients with a rare gene disorder called Danon disease, investors in the company's shares saw

Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman

(NYSE:CNC), SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) — Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action- Hagens Berman

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action- Hagens Berman GlobeNewswire July 17, 2025 SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) — When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an

Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman

Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman GlobeNewswire July 17, 2025 SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) — Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic

Market Veep Earns Official Women-Owned Business Certification from Center for Women & Enterprise (WBENC)

Recognition Affirms Founder's Leadership and Commitment to Women's Representation in Business Market Veep, a leading inbound marketing agency specializing in B2B lead generation, is proud to announce that it has been officially certified as a Women-Owned Business Enterprise (WBENC) by the Center for Women & Enterprise Certification Committee. https://mma.prnewswire.com/media/2430108/Market_Veep_Logo.jpg This prestigious certification, issued by CWE

Liberty HealthShare Gets Another GuideStar Gold Seal

— Earned GuideStar Gold Seal Four Straight Years — Received Charity Navigator 4-Star Rating for 2025 — Only Healthshare Ministry with Both Gold Seal and 4-Star Rating For the fourth straight year, Liberty HealthShare® has been awarded the GuideStar Gold Seal by Candid, ranking it among the country's best non-profit organizations for transparency and accountability.

Ink Films Announces Feature-Length Animated Shorts Program Curated by Don Hertzfeldt: Animation Mixtape

Set for exclusive theatrical release Fall 2025 Ink Films, the newly launched theatrical distribution arm of The Beverly Theater, announces the title of its debut release: Animation Mixtape, presented by two-time Academy Award nominee Don Hertzfeldt. This feature-length collection of animated short films will be screened exclusively in theaters across North America beginning Fall 2025.

Tamarack Resort Unveils Summer & Fall 2025 Event Lineup

A Season of Music, Art, Adventure, and The Mountains as They Should Be Tamarack Resort is excited to share its most vibrant summer and fall calendar to date. From signature mountain festivals to fresh weekly traditions, the 2025 season is packed with music, flavor, creativity, and endless alpine energy. Guests can also enjoy daily scenic

Scroll to Top